Kolon Life Science Inc. (KOSDAQ: 102940)

Kolon Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	25,564	7,561	6,371	27,800	15,001	5,914
Short-Term Investments	-	-	-	110	30	15,000
Cash & Short-Term Investments	25,564	7,561	6,371	27,910	15,031	20,914
Cash Growth	-1.85%	18.68%	-77.17%	85.69%	-28.13%	29.92%
Accounts Receivable	33,665	24,605	29,440	19,649	22,199	28,526
Other Receivables	1,032	1,008	302.04	638.16	398.12	931.53
Receivables	34,696	25,613	29,742	20,287	22,597	29,457
Inventory	49,051	67,777	68,494	45,998	42,790	36,064
Prepaid Expenses	3,713	3,406	4,579	3,743	7,237	4,441
Other Current Assets	1,165	688.31	998.16	82.57	12,908	284.2
Total Current Assets	114,189	105,045	110,184	98,021	100,563	91,160
Property, Plant & Equipment	118,841	123,138	125,960	131,481	141,893	178,398
Long-Term Investments	119,072	77,054	75,240	2,549	3,262	2,143
Goodwill	-	-	1,217	1,217	1,217	1,217
Other Intangible Assets	516.6	168.28	58.95	99.11	199.79	258.57
Long-Term Accounts Receivable	-0	0	-0	-0	-0	-0
Long-Term Deferred Charges	104.55	164.25	283.64	403.04	522.43	641.82
Other Long-Term Assets	3,632	3,866	1,174	888.54	680.57	4,477
Total Assets	356,355	309,436	314,118	234,658	248,338	278,295
Accounts Payable	11,819	11,547	17,049	13,774	11,808	10,714
Accrued Expenses	6,725	4,355	3,594	3,145	2,721	1,898
Short-Term Debt	114,400	97,262	69,461	59,064	61,751	53,742
Current Portion of Long-Term Debt	4,995	-	4,000	5,333	5,333	6,520
Current Portion of Leases	472.87	428.66	287.62	336.45	348.65	233.03
Current Income Taxes Payable	-	-	376.36	-	-	-
Current Unearned Revenue	3,201	3,201	3,201	3,500	3,500	3,500
Other Current Liabilities	41,427	11,547	11,608	10,316	59,689	49,565
Total Current Liabilities	183,041	128,341	109,578	95,469	145,152	126,173
Long-Term Debt	4,991	9,980	-	4,000	9,333	18,095
Long-Term Leases	236.02	191.33	167.18	191.02	262.15	142.56
Long-Term Deferred Tax Liabilities	17,843	9,874	9,760	-	-	-
Other Long-Term Liabilities	15,628	16,938	17,078	25,139	25,903	25,249
Total Liabilities	228,585	171,764	146,395	135,248	190,381	177,274
Common Stock	6,166	5,706	5,706	5,706	5,706	5,706
Additional Paid-In Capital	228,643	209,114	209,114	209,542	167,980	167,980
Retained Earnings	-197,227	-133,289	-101,537	-106,024	-104,359	-61,361
Treasury Stock	-	-	-	-812.88	-812.88	-812.88
Comprensive Income & Other	90,189	56,140	54,440	-9,001	-10,557	-10,493
Total Common Equity	127,770	137,672	167,723	99,410	57,957	101,020
Shareholders' Equity	127,770	137,672	167,723	99,410	57,957	101,020
Total Liabilities & Equity	356,355	309,436	314,118	234,658	248,338	278,295
Total Debt	125,095	107,863	73,916	68,925	77,029	78,733
Net Cash (Debt)	-99,532	-100,301	-67,545	-41,015	-61,998	-57,820
Net Cash Per Share	-8700.63	-8788.83	-5344.94	-3597.74	-5438.33	-5071.55
Filing Date Shares Outstanding	12.42	11.41	11.41	11.4	11.4	11.4
Total Common Shares Outstanding	12.33	11.41	11.41	11.4	11.4	11.4
Working Capital	-68,851	-23,296	606.75	2,552	-44,589	-35,013
Book Value Per Share	10361.31	12063.41	14696.64	8720.06	5083.88	8861.31
Tangible Book Value	127,254	137,504	166,448	98,094	56,541	99,545
Tangible Book Value Per Share	10319.42	12048.67	14584.86	8604.64	4959.63	8731.90
Land	16,281	16,281	17,286	17,008	17,024	22,009
Buildings	65,342	88,069	88,567	88,891	88,874	108,745
Machinery	18,947	104,638	101,589	102,952	90,469	90,101
Construction In Progress	17,551	17,810	16,474	15,952	28,846	30,798

Source: S&P Capital IQ. Standard template. Financial Sources.